PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
-4.65%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$1.73B
AUM Growth
+$1.73B
(+1.4%)
Cap. Flow
+$120M
Cap. Flow
% of AUM
6.96%
Top 10 Holdings %
Top 10 Hldgs %
64.87%
Holding
130
New
15
Increased
46
Reduced
33
Closed
15
Top Buys
| 1 |
UBS Group
UBS
|
$132M |
| 2 |
Merck
MRK
|
$92.9M |
| 3 |
AbbVie
ABBV
|
$87.7M |
| 4 |
Lam Research
LRCX
|
$82M |
| 5 |
Valaris
VAL
|
$56.5M |
Top Sells
| 1 |
Nice
NICE
|
$68.8M |
| 2 |
Lamb Weston
LW
|
$67M |
| 3 |
Intercontinental Exchange
ICE
|
$64.6M |
| 4 |
Pinduoduo
PDD
|
$46.7M |
| 5 |
Baxter International
BAX
|
$44M |
Sector Composition
| 1 | Financials | 22.28% |
| 2 | Technology | 16.49% |
| 3 | Energy | 15.11% |
| 4 | Healthcare | 14.95% |
| 5 | Industrials | 11.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Codexis
CDXS
$246M
| $851K | 0.05% | 316,383 +116,320 | +58% | +$313K |
|
77
Intel
INTC
$107B
| $809K | 0.05% | 35,620 +22,449 | +170% | +$510K |
|
78
Cogent Biosciences
COGT
$1.69B
| $802K | 0.05% | 133,910 -23,941 | -15% | -$143K |
|
79
Kura Oncology
KURA
$686M
| $505K | 0.03% | 76,533 | – | – |
|
80
Skye Bioscience
SKYE
$108M
| $466K | 0.03% | 293,320 -140,726 | -32% | -$224K |
|
81
Liberty Broadband Class C
LBRDK
$8.73B
| $425K | 0.02% | 4,998 +3,251 | +186% | +$276K |
|
82
Texas Instruments
TXN
$184B
| $408K | 0.02% | 2,270 -8,723 | -79% | -$1.57M |
|
83
Analog Devices
ADI
$124B
| $388K | 0.02% | +1,922 | New | +$388K |
|
|
ANSS
84
DELISTED
Ansys
ANSS
| $374K | 0.02% | 1,182 | – | – |
|
85
Duolingo
DUOL
$13.6B
| $313K | 0.02% | +1,007 | New | +$313K |
|
86
Dollar General
DG
$23.9B
| $306K | 0.02% | 3,476 +2,326 | +202% | +$205K |
|
|
FLG
87
Flagstar Financial, Inc.
FLG
$5.33B
| $306K | 0.02% | 26,302 +16,792 | +177% | +$195K |
|
88
Universal Health Services
UHS
$11.6B
| $302K | 0.02% | 1,608 +1,120 | +230% | +$210K |
|
89
Core Laboratories
CLB
$540M
| $300K | 0.02% | 20,025 +14,927 | +293% | +$224K |
|
90
Sempra
SRE
$53.9B
| $297K | 0.02% | 4,159 +2,683 | +182% | +$191K |
|
91
Cigna
CI
$80.3B
| $297K | 0.02% | 902 +586 | +185% | +$193K |
|
92
Corcept Therapeutics
CORT
$7.35B
| $297K | 0.02% | 2,598 +1,742 | +204% | +$199K |
|
93
HCA Healthcare
HCA
$94.5B
| $292K | 0.02% | 846 +554 | +190% | +$191K |
|
94
Noble Corp
NE
$4.58B
| $291K | 0.02% | 12,268 +9,406 | +329% | +$223K |
|
95
CVS Health
CVS
$92.8B
| $291K | 0.02% | 4,291 +2,311 | +117% | +$157K |
|
96
RH
RH
$4.23B
| $290K | 0.02% | +1,238 | New | +$290K |
|
97
Kohl's
KSS
$1.69B
| $290K | 0.02% | 35,429 +29,321 | +480% | +$240K |
|
98
OneMain Financial
OMF
$7.35B
| $280K | 0.02% | 5,721 +4,055 | +243% | +$198K |
|
99
Tyson Foods
TSN
$20.2B
| $277K | 0.02% | 4,337 +2,814 | +185% | +$180K |
|
100
General Mills
GIS
$26.4B
| $271K | 0.02% | +4,535 | New | +$271K |
|